Upstream Bio (UPB) Cash from Investing Activities (2023 - 2026)

Upstream Bio's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at $42.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 119.87% year-over-year to $42.4 million; the TTM figure through Mar 2026 stood at $162.3 million (up 156.61% YoY), while the FY2025 annual figure was -$93.5 million, down 57.15% from the prior year.
• Cash from Investing Activities was $42.4 million for Q1 2026 at Upstream Bio, down from $58.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $58.9 million in Q4 2025 to a low of -$213.4 million in Q1 2025.
• Historically, Cash from Investing Activities has averaged -$11.6 million across 4 years, with a median of $13.3 million in 2024.
• Biggest YoY gain for Cash from Investing Activities was 3319.87% in 2025; the steepest drop was 1640.43% in 2025.
• A 4-year view of Cash from Investing Activities shows it stood at -$5.2 million in 2023, then soared by 899.47% to $41.9 million in 2024, then surged by 40.65% to $58.9 million in 2025, then decreased by 28.06% to $42.4 million in 2026.
• The last three Cash from Investing Activities figures came in at $42.4 million (Q1 2026), $58.9 million (Q4 2025), and $48.2 million (Q3 2025), per Business Quant data.